JP2023165999A5 - - Google Patents

Download PDF

Info

Publication number
JP2023165999A5
JP2023165999A5 JP2023170375A JP2023170375A JP2023165999A5 JP 2023165999 A5 JP2023165999 A5 JP 2023165999A5 JP 2023170375 A JP2023170375 A JP 2023170375A JP 2023170375 A JP2023170375 A JP 2023170375A JP 2023165999 A5 JP2023165999 A5 JP 2023165999A5
Authority
JP
Japan
Prior art keywords
tablet
magnesium oxide
suspended
particle diameter
volume
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023170375A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023165999A (ja
JP7657275B2 (ja
Filing date
Publication date
Priority claimed from JP2020556190A external-priority patent/JP7111389B2/ja
Application filed filed Critical
Publication of JP2023165999A publication Critical patent/JP2023165999A/ja
Publication of JP2023165999A5 publication Critical patent/JP2023165999A5/ja
Application granted granted Critical
Publication of JP7657275B2 publication Critical patent/JP7657275B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023170375A 2018-11-16 2023-09-29 緩下用錠剤 Active JP7657275B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2018215180 2018-11-16
JP2018215180 2018-11-16
JP2020556190A JP7111389B2 (ja) 2018-11-16 2019-11-15 緩下用錠剤
PCT/JP2019/044876 WO2020101016A1 (ja) 2018-11-16 2019-11-15 緩下用錠剤
JP2022087199A JP7360503B2 (ja) 2018-11-16 2022-05-27 緩下用錠剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022087199A Division JP7360503B2 (ja) 2018-11-16 2022-05-27 緩下用錠剤

Publications (3)

Publication Number Publication Date
JP2023165999A JP2023165999A (ja) 2023-11-17
JP2023165999A5 true JP2023165999A5 (cg-RX-API-DMAC7.html) 2023-12-13
JP7657275B2 JP7657275B2 (ja) 2025-04-04

Family

ID=70731929

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020556190A Active JP7111389B2 (ja) 2018-11-16 2019-11-15 緩下用錠剤
JP2022087199A Active JP7360503B2 (ja) 2018-11-16 2022-05-27 緩下用錠剤
JP2023170375A Active JP7657275B2 (ja) 2018-11-16 2023-09-29 緩下用錠剤

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2020556190A Active JP7111389B2 (ja) 2018-11-16 2019-11-15 緩下用錠剤
JP2022087199A Active JP7360503B2 (ja) 2018-11-16 2022-05-27 緩下用錠剤

Country Status (7)

Country Link
US (1) US12053549B2 (cg-RX-API-DMAC7.html)
EP (1) EP3881897B1 (cg-RX-API-DMAC7.html)
JP (3) JP7111389B2 (cg-RX-API-DMAC7.html)
KR (1) KR102682646B1 (cg-RX-API-DMAC7.html)
CN (1) CN113015555B (cg-RX-API-DMAC7.html)
TW (1) TWI724629B (cg-RX-API-DMAC7.html)
WO (1) WO2020101016A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021457908B9 (en) * 2021-07-30 2026-02-05 Setolas Holdings, Inc. Magnesium oxide-containing pharmaceutical composition for treating pediatric chronic functional constipation
JP7340572B2 (ja) * 2021-08-20 2023-09-07 セトラスホールディングス株式会社 酸化マグネシウム錠剤
CN115487160A (zh) * 2022-09-27 2022-12-20 威海百合生物技术股份有限公司 一种氧化镁片及其制备方法
CN120036483B (zh) * 2025-01-06 2026-03-27 仙乐健康科技股份有限公司 一种微胶囊、片剂及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8710965D0 (en) 1987-05-08 1987-06-10 Smith Kline French Lab Pharmaceutical compositions
KR100972773B1 (ko) * 2001-08-27 2010-07-30 교와 가가꾸고교 가부시키가이샤 제산 ·완하용 정제
JP4015485B2 (ja) 2001-08-27 2007-11-28 協和化学工業株式会社 制酸・緩下用錠剤
JP2006022060A (ja) 2004-07-09 2006-01-26 Kyowa Chem Ind Co Ltd 制酸・緩下用水分散液およびそのための錠剤
DK1973529T3 (da) 2006-01-05 2011-09-12 Veloxis Pharmaceuticals As Fyldbar tablet, som er i stand til at falde hen
WO2008140772A2 (en) * 2007-05-08 2008-11-20 Hercules Incorporated Robust rapid disintegration tablet formulation
MX2009012210A (es) 2007-05-11 2010-01-26 Aloebiotics Res Labs Inc Preparacion de aloe para el mejoramiento de la piel.
JP2010265208A (ja) 2009-05-14 2010-11-25 Kyowa Chem Ind Co Ltd 膵臓機能強化乃至活性化用複合酸化マグネシウム粒子
US20120156293A1 (en) * 2009-09-08 2012-06-21 Hideaki Kitajima Antacid and laxative tablet
JP2014224080A (ja) * 2013-05-17 2014-12-04 協和化学工業株式会社 大腸の検査または手術のための処置剤

Similar Documents

Publication Publication Date Title
SI2760821T1 (en) A salt salt of an anti-inflammatory substituted cyclobutenedione compound
RU2006118689A (ru) Содержащий фармацевтический агент состав с покрытием
JP2003502359A5 (cg-RX-API-DMAC7.html)
MXPA05008033A (es) Composiciones de milnacipran en forma de multiparticulas para administracion oral.
WO2011160541A1 (zh) 托伐普坦固体分散体及其制备方法
US5288507A (en) Ibuprofen antacid combinations
ITMI941262A1 (it) Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo
JP2020128429A5 (cg-RX-API-DMAC7.html)
JPS63201184A (ja) ５−クロロ−３−（２−テノイル）−２−オキシインドール−１−カルボキサミドの無水結晶ナトリウム塩およびその製法
CN108289847A (zh) 基于二氧化硅的抗菌口腔用组合物
PL375919A1 (en) Coated peroxygen compounds with controlled release, a process for their preparation and their use
JPWO2006118017A1 (ja) 安定化組成物
CA2050970C (en) Pharmaceutical compositions containing furan derivatives
JP2024009126A5 (cg-RX-API-DMAC7.html)
JPH05155776A (ja) 高リン血症治療剤
JP5232641B2 (ja) 新規なアセチルサリチル酸製剤
US5785995A (en) Pharmaceutical tablet of amiodarone salt
JP2009035545A5 (cg-RX-API-DMAC7.html)
JP2015187096A (ja) 固形製剤
JPH03120211A (ja) 粒状カルニチン製剤
JP2024530268A5 (cg-RX-API-DMAC7.html)
US2846352A (en) Vitamin compositions and method for producing the same
JPS5822011B2 (ja) 安定なダントロレンナトリウムの製剤
JP2021070685A5 (cg-RX-API-DMAC7.html)
JP6965497B2 (ja) レボセチリジン固形製剤